Abbott’s AndroGel for hypogonadism treatment in men approved

U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

Nearly 14 million men in the United States may have low testosterone levels.  The Endocrine Society developed guidelines for the diagnosis and treatment of hypogonadism, which note the normal range for testosterone as 300-1,000 ng/dL.